Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
activist investor
Pharma
Sanofi bolsters adult vaccine roster with $2.2B Dynavax purchase
Following an activist investor feud earlier this year, vaccine developer Dynavax Technologies has agreed to sell itself to France’s Sanofi.
Fraiser Kansteiner
Dec 29, 2025 10:24am
Fierce Biotech
Why 'emboldened' investors are taking the fight to biotechs
Jul 2, 2025 9:15am
Activist investor Icahn takes 34% interest in Bausch Health
Apr 22, 2025 6:39pm
Another activist investor sets its sights on Kenvue: Bloomberg
Mar 24, 2025 10:38am
Investor group calls for strategy shift at struggling Amarin
Mar 20, 2025 11:00am
Pfizer avoids board nominations from Starboard: Bloomberg
Jan 27, 2025 2:45pm